Drug intelligence / Profile preview

AVIM + Virtue SAB

Development stage
Unknown
Lead developer
Orchestra BioMed
Modality
Small Molecules
Administration
Intravascular, Intracardiac
01

Overview

AVIM + Virtue SAB refers to the two lead product candidates from Orchestra BioMed: Atrioventricular Interval Modulation (AVIM) Therapy and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB). AVIM Therapy is a bioelectronic treatment delivered via a standard pacemaker, designed to achieve immediate and sustained blood pressure reduction in patients with hypertensive heart disease by modulating the atrioventricular interval. Virtue SAB is a first-of-its-kind, non-coated drug delivery angioplasty balloon system that delivers a proprietary extended-release liquid formulation of sirolimus (SirolimusEFR) directly into the vessel wall for the treatment of atherosclerotic artery disease, including coronary in-stent restenosis, small vessel disease, and peripheral artery disease.

Other names
AVIM TherapyVirtue Sirolimus AngioInfusion BalloonSirolimusEFR
02

Targets

FKBP1AMechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on AVIM + Virtue SAB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVIM + Virtue SAB.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call